-
1 Comment
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.7.
Based on the above factors, ImmunoPrecise Antibodies Ltd gets an overall score of 1/5.
Exchange | NASDAQ |
---|---|
CurrencyCode | USD |
Industry | Biotechnology |
ISIN | CA45257F2008 |
Sector | Healthcare |
PE Ratio | None |
---|---|
Beta | 0.55 |
Market Cap | 96M |
Target Price | 4 |
Dividend Yield | None |
ImmunoPrecise Antibodies Ltd. operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company. It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IPA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025